Shopping Cart
- Remove All
Your shopping cart is currently empty
Pirepemat fumarate
😃Good
Catalog No. T60950Cas No. 2251806-70-7
Pirepemat (IRL752) fumarate can be used in Parkinson's disease study. Pirepemat is a cortical-preferring catecholamine transmission- and cognition-promoting agent [1] [2].
Pirepemat fumarate
😃Good
Catalog No. T60950Cas No. 2251806-70-7
Pirepemat (IRL752) fumarate can be used in Parkinson's disease study. Pirepemat is a cortical-preferring catecholamine transmission- and cognition-promoting agent [1] [2].
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $916 | 6-8 weeks | |
| 50 mg | $1,190 | 6-8 weeks | |
| 100 mg | $1,860 | 6-8 weeks |
Bulk & Custom
Add to Cart
Questions
View MoreContact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | Pirepemat (IRL752) fumarate can be used in Parkinson's disease study. Pirepemat is a cortical-preferring catecholamine transmission- and cognition-promoting agent [1] [2]. |
| In vitro | IRL752 fumarate exhibits its strongest in vitro affinities primarily for serotonin (5-HT) and norepinephrine (NA)-related targets [2]. |
| In vivo | IRL752 fumarate, administered subcutaneously at dosages ranging from 3.7 to 100 μmol/kg, does not significantly influence acute hyperdopaminergic or hypoglutamatergic motor responses. However, it effectively reverses impairments associated with reduced monoaminergic function. In normal rats tested 30 minutes after administration, IRL752 induced dose-dependent and region-specific changes in brain monoamine transmission indices and gene expression, showcasing its potential in modulating neurotransmitter system dysfunctions. |
| Molecular Weight | 329.3 |
| Formula | C15H17F2NO5 |
| Cas No. | 2251806-70-7 |
Storage & Solubility Information
| Storage | Shipping with blue ice. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Pirepemat fumarate | purchase Pirepemat fumarate | Pirepemat fumarate cost | order Pirepemat fumarate | Pirepemat fumarate chemical structure | Pirepemat fumarate in vivo | Pirepemat fumarate in vitro | Pirepemat fumarate formula | Pirepemat fumarate molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.